Ceva Animal Health has announced that Vectra 3D spot-on solution for dogs and Vectra Felis 423mg/42.3mg spot-on solution for cats have been recategorised from POM-V to NFA-VPS products.

The re-categorisation means veterinary practices can sell the topical parasiticides to ‘walk-in clients’ without the need of a prescription. 

Andrew Fullerton, veterinary surgeon and product manager at Ceva Animal Health, said: “The new NFA-VPS category for Vectra 3D spot-on solution for dogs and Vectra Felis 423mg/42.3mg spot-on solution for cats provides veterinary practices with greater flexibility to sell easy-to-use, fast and effective parasite prevention and treatment without a prescription."

For more information, contact your Ceva Animal Health account manager or email cevauk@ceva.com.

PS: Whilst you're here, take a moment to see our latest job opportunities for vet nurses.